id	sid	tid	token	lemma	pos
dpc-4184	1	1	dermatology	dermatology	NOUN
dpc-4184	1	2	:	:	PUNCT
dpc-4184	1	3	practical	practical	ADJ
dpc-4184	1	4	and	and	CCONJ
dpc-4184	1	5	conceptual	conceptual	ADJ
dpc-4184	1	6	image	image	NOUN
dpc-4184	1	7	letter	letter	NOUN
dpc-4184	2	1	|	|	ADV
dpc-4184	2	2	dermatol	dermatol	ADJ
dpc-4184	2	3	pract	pract	NOUN
dpc-4184	2	4	concept	concept	NOUN
dpc-4184	2	5	.	.	PUNCT
dpc-4184	3	1	2024;14(3):e2024185	2024;14(3):e2024185	NUM
dpc-4184	3	2	1	1	NUM
dpc-4184	3	3	new	new	ADJ
dpc-4184	3	4	-	-	PUNCT
dpc-4184	3	5	onset	onset	NOUN
dpc-4184	3	6	blepharitis	blepharitis	NOUN
dpc-4184	3	7	in	in	ADP
dpc-4184	3	8	patient	patient	NOUN
dpc-4184	3	9	treated	treat	VERB
dpc-4184	3	10	with	with	ADP
dpc-4184	3	11	secukinumab	secukinumab	NOUN
dpc-4184	3	12	for	for	ADP
dpc-4184	3	13	severe	severe	ADJ
dpc-4184	3	14	psoriasis	psoriasis	NOUN
dpc-4184	3	15	maria	maria	PROPN
dpc-4184	3	16	francesca	francesca	PROPN
dpc-4184	3	17	baracca1,2	baracca1,2	PROPN
dpc-4184	3	18	,	,	PUNCT
dpc-4184	3	19	filippo	filippo	PROPN
dpc-4184	3	20	viviani1,2	viviani1,2	PROPN
dpc-4184	3	21	,	,	PUNCT
dpc-4184	3	22	alessandro	alessandro	PROPN
dpc-4184	3	23	pileri1,2	pileri1,2	PROPN
dpc-4184	3	24	,	,	PUNCT
dpc-4184	3	25	giacomo	giacomo	PROPN
dpc-4184	3	26	clarizio1,2	clarizio1,2	PROPN
dpc-4184	3	27	,	,	PUNCT
dpc-4184	3	28	federico	federico	PROPN
dpc-4184	3	29	bardazzi1	bardazzi1	NOUN
dpc-4184	3	30	1	1	NUM
dpc-4184	3	31	dermatology	dermatology	NOUN
dpc-4184	3	32	unit	unit	NOUN
dpc-4184	3	33	,	,	PUNCT
dpc-4184	3	34	irccs	irccs	PROPN
dpc-4184	3	35	azienda	azienda	PROPN
dpc-4184	3	36	ospedaliero	ospedaliero	PROPN
dpc-4184	3	37	-	-	PUNCT
dpc-4184	3	38	universitaria	universitaria	PROPN
dpc-4184	3	39	di	di	PROPN
dpc-4184	3	40	bologna	bologna	PROPN
dpc-4184	3	41	,	,	PUNCT
dpc-4184	3	42	policlinico	policlinico	PROPN
dpc-4184	3	43	s.	s.	PROPN
dpc-4184	3	44	orsola	orsola	PROPN
dpc-4184	3	45	-	-	PUNCT
dpc-4184	3	46	malpighi	malpighi	PROPN
dpc-4184	3	47	,	,	PUNCT
dpc-4184	3	48	bologna	bologna	PROPN
dpc-4184	3	49	,	,	PUNCT
dpc-4184	3	50	italy	italy	PROPN
dpc-4184	3	51	2	2	NUM
dpc-4184	3	52	department	department	NOUN
dpc-4184	3	53	of	of	ADP
dpc-4184	3	54	medical	medical	ADJ
dpc-4184	3	55	and	and	CCONJ
dpc-4184	3	56	surgical	surgical	ADJ
dpc-4184	3	57	sciences	science	NOUN
dpc-4184	3	58	,	,	PUNCT
dpc-4184	3	59	alma	alma	NOUN
dpc-4184	3	60	mater	mater	PROPN
dpc-4184	3	61	studiorum	studiorum	PROPN
dpc-4184	3	62	university	university	PROPN
dpc-4184	3	63	of	of	ADP
dpc-4184	3	64	bologna	bologna	PROPN
dpc-4184	3	65	,	,	PUNCT
dpc-4184	3	66	bologna	bologna	PROPN
dpc-4184	3	67	,	,	PUNCT
dpc-4184	3	68	italy	italy	PROPN
dpc-4184	3	69	citation	citation	NOUN
dpc-4184	3	70	:	:	PUNCT
dpc-4184	3	71	baracca	baracca	ADP
dpc-4184	3	72	mf	mf	NOUN
dpc-4184	3	73	,	,	PUNCT
dpc-4184	3	74	viviani	viviani	PROPN
dpc-4184	3	75	f	f	PROPN
dpc-4184	3	76	,	,	PUNCT
dpc-4184	3	77	pileri	pileri	PROPN
dpc-4184	3	78	a	a	PRON
dpc-4184	3	79	,	,	PUNCT
dpc-4184	3	80	clarizio	clarizio	NOUN
dpc-4184	3	81	g	g	NOUN
dpc-4184	3	82	,	,	PUNCT
dpc-4184	3	83	bardazzi	bardazzi	PROPN
dpc-4184	3	84	f.	f.	PROPN
dpc-4184	3	85	new	new	ADJ
dpc-4184	3	86	-	-	PUNCT
dpc-4184	3	87	onset	onset	NOUN
dpc-4184	3	88	blepharitis	blepharitis	NOUN
dpc-4184	3	89	in	in	ADP
dpc-4184	3	90	patient	patient	NOUN
dpc-4184	3	91	treated	treat	VERB
dpc-4184	3	92	with	with	ADP
dpc-4184	3	93	secukinumab	secukinumab	NOUN
dpc-4184	3	94	for	for	ADP
dpc-4184	3	95	severe	severe	ADJ
dpc-4184	3	96	psoriasis	psoriasis	NOUN
dpc-4184	3	97	.	.	PUNCT
dpc-4184	4	1	dermatol	dermatol	NOUN
dpc-4184	4	2	pract	pract	PROPN
dpc-4184	4	3	concept	concept	NOUN
dpc-4184	4	4	.	.	PUNCT
dpc-4184	5	1	2024;14(3):e2024185	2024;14(3):e2024185	X
dpc-4184	5	2	.	.	X
dpc-4184	5	3	doi	doi	NOUN
dpc-4184	5	4	:	:	PUNCT
dpc-4184	5	5	https://doi.org/10.5826/dpc.1403a185	https://doi.org/10.5826/dpc.1403a185	PROPN
dpc-4184	5	6	accepted	accept	VERB
dpc-4184	5	7	:	:	PUNCT
dpc-4184	5	8	february	february	PROPN
dpc-4184	5	9	14	14	NUM
dpc-4184	5	10	,	,	PUNCT
dpc-4184	5	11	2024	2024	NUM
dpc-4184	5	12	;	;	PUNCT
dpc-4184	5	13	published	publish	VERB
dpc-4184	5	14	:	:	PUNCT
dpc-4184	6	1	july	july	PROPN
dpc-4184	6	2	2024	2024	NUM
dpc-4184	6	3	copyright	copyright	NOUN
dpc-4184	6	4	:	:	PUNCT
dpc-4184	6	5	©	©	PROPN
dpc-4184	6	6	2024	2024	NUM
dpc-4184	6	7	baracca	baracca	X
dpc-4184	6	8	et	et	PROPN
dpc-4184	6	9	al	al	PROPN
dpc-4184	6	10	.	.	PUNCT
dpc-4184	7	1	this	this	PRON
dpc-4184	7	2	is	be	AUX
dpc-4184	7	3	an	an	DET
dpc-4184	7	4	open	open	ADJ
dpc-4184	7	5	-	-	PUNCT
dpc-4184	7	6	access	access	NOUN
dpc-4184	7	7	article	article	NOUN
dpc-4184	7	8	distributed	distribute	VERB
dpc-4184	7	9	under	under	ADP
dpc-4184	7	10	the	the	DET
dpc-4184	7	11	terms	term	NOUN
dpc-4184	7	12	of	of	ADP
dpc-4184	7	13	the	the	DET
dpc-4184	7	14	creative	creative	ADJ
dpc-4184	7	15	commons	common	NOUN
dpc-4184	7	16	attributionnoncommercial	attributionnoncommercial	ADJ
dpc-4184	7	17	license	license	NOUN
dpc-4184	7	18	(	(	PUNCT
dpc-4184	7	19	by	by	ADP
dpc-4184	7	20	-	-	PUNCT
dpc-4184	7	21	nc-4.0	nc-4.0	NOUN
dpc-4184	7	22	)	)	PUNCT
dpc-4184	7	23	,	,	PUNCT
dpc-4184	7	24	https://creativecommons.org/licenses/by-nc/4.0/	https://creativecommons.org/licenses/by-nc/4.0/	PROPN
dpc-4184	7	25	,	,	PUNCT
dpc-4184	7	26	which	which	PRON
dpc-4184	7	27	permits	permit	VERB
dpc-4184	7	28	unrestricted	unrestricted	ADJ
dpc-4184	7	29	noncommercial	noncommercial	ADJ
dpc-4184	7	30	use	use	NOUN
dpc-4184	7	31	,	,	PUNCT
dpc-4184	7	32	distribution	distribution	NOUN
dpc-4184	7	33	,	,	PUNCT
dpc-4184	7	34	and	and	CCONJ
dpc-4184	7	35	reproduction	reproduction	NOUN
dpc-4184	7	36	in	in	ADP
dpc-4184	7	37	any	any	DET
dpc-4184	7	38	medium	medium	NOUN
dpc-4184	7	39	,	,	PUNCT
dpc-4184	7	40	provided	provide	VERB
dpc-4184	7	41	the	the	DET
dpc-4184	7	42	original	original	ADJ
dpc-4184	7	43	authors	author	NOUN
dpc-4184	7	44	and	and	CCONJ
dpc-4184	7	45	source	source	NOUN
dpc-4184	7	46	are	be	AUX
dpc-4184	7	47	credited	credit	VERB
dpc-4184	7	48	.	.	PUNCT
dpc-4184	8	1	funding	funding	NOUN
dpc-4184	8	2	:	:	PUNCT
dpc-4184	8	3	none	none	NOUN
dpc-4184	8	4	.	.	PUNCT
dpc-4184	9	1	competing	compete	VERB
dpc-4184	9	2	interests	interest	NOUN
dpc-4184	9	3	:	:	PUNCT
dpc-4184	9	4	none	none	NOUN
dpc-4184	9	5	.	.	PUNCT
dpc-4184	10	1	authorship	authorship	NOUN
dpc-4184	10	2	:	:	PUNCT
dpc-4184	10	3	all	all	DET
dpc-4184	10	4	authors	author	NOUN
dpc-4184	10	5	have	have	AUX
dpc-4184	10	6	contributed	contribute	VERB
dpc-4184	10	7	significantly	significantly	ADV
dpc-4184	10	8	to	to	ADP
dpc-4184	10	9	this	this	DET
dpc-4184	10	10	publication	publication	NOUN
dpc-4184	10	11	.	.	PUNCT
dpc-4184	11	1	corresponding	correspond	VERB
dpc-4184	11	2	author	author	NOUN
dpc-4184	11	3	:	:	PUNCT
dpc-4184	11	4	maria	maria	PROPN
dpc-4184	11	5	francesca	francesca	PROPN
dpc-4184	11	6	baracca	baracca	PROPN
dpc-4184	11	7	,	,	PUNCT
dpc-4184	11	8	via	via	ADP
dpc-4184	11	9	massarenti	massarenti	NOUN
dpc-4184	11	10	9	9	NUM
dpc-4184	11	11	,	,	PUNCT
dpc-4184	11	12	40138	40138	NUM
dpc-4184	11	13	bologna	bologna	PROPN
dpc-4184	11	14	,	,	PUNCT
dpc-4184	11	15	italy	italy	PROPN
dpc-4184	11	16	.	.	PUNCT
dpc-4184	12	1	telephone	telephone	NOUN
dpc-4184	12	2	/	/	SYM
dpc-4184	12	3	fax	fax	NOUN
dpc-4184	12	4	:	:	PUNCT
dpc-4184	12	5	+390512144843	+390512144843	NUM
dpc-4184	12	6	.	.	PUNCT
dpc-4184	13	1	email	email	NOUN
dpc-4184	13	2	:	:	PUNCT
dpc-4184	13	3	maria.baracca@studio.unibo.it	maria.baracca@studio.unibo.it	PRON
dpc-4184	13	4	case	case	NOUN
dpc-4184	13	5	presentation	presentation	NOUN
dpc-4184	13	6	a	a	DET
dpc-4184	13	7	63	63	NUM
dpc-4184	13	8	-	-	PUNCT
dpc-4184	13	9	year	year	NOUN
dpc-4184	13	10	-	-	PUNCT
dpc-4184	13	11	old	old	ADJ
dpc-4184	13	12	woman	woman	NOUN
dpc-4184	13	13	with	with	ADP
dpc-4184	13	14	a	a	DET
dpc-4184	13	15	4	4	NUM
dpc-4184	13	16	-	-	PUNCT
dpc-4184	13	17	year	year	NOUN
dpc-4184	13	18	history	history	NOUN
dpc-4184	13	19	of	of	ADP
dpc-4184	13	20	severe	severe	ADJ
dpc-4184	13	21	psoriasis	psoriasis	NOUN
dpc-4184	13	22	presented	present	VERB
dpc-4184	13	23	for	for	ADP
dpc-4184	13	24	recurrence	recurrence	NOUN
dpc-4184	13	25	despite	despite	SCONJ
dpc-4184	13	26	initial	initial	ADJ
dpc-4184	13	27	clinical	clinical	ADJ
dpc-4184	13	28	improvement	improvement	NOUN
dpc-4184	13	29	with	with	ADP
dpc-4184	13	30	brodalumab	brodalumab	NOUN
dpc-4184	13	31	,	,	PUNCT
dpc-4184	13	32	started	start	VERB
dpc-4184	13	33	2	2	NUM
dpc-4184	13	34	years	year	NOUN
dpc-4184	13	35	previously	previously	ADV
dpc-4184	13	36	.	.	PUNCT
dpc-4184	14	1	she	she	PRON
dpc-4184	14	2	was	be	AUX
dpc-4184	14	3	switched	switch	VERB
dpc-4184	14	4	to	to	ADP
dpc-4184	14	5	another	another	DET
dpc-4184	14	6	interleukin-17	interleukin-17	ADJ
dpc-4184	14	7	inhibitor	inhibitor	NOUN
dpc-4184	14	8	(	(	PUNCT
dpc-4184	14	9	anti	anti	ADJ
dpc-4184	14	10	-	-	ADJ
dpc-4184	14	11	il-17	il-17	NUM
dpc-4184	14	12	)	)	PUNCT
dpc-4184	14	13	,	,	PUNCT
dpc-4184	14	14	secukinumab	secukinumab	NOUN
dpc-4184	14	15	,	,	PUNCT
dpc-4184	14	16	and	and	CCONJ
dpc-4184	14	17	rapid	rapid	ADJ
dpc-4184	14	18	clearance	clearance	NOUN
dpc-4184	14	19	of	of	ADP
dpc-4184	14	20	the	the	DET
dpc-4184	14	21	erythematous	erythematous	ADJ
dpc-4184	14	22	-	-	PUNCT
dpc-4184	14	23	desquamative	desquamative	ADJ
dpc-4184	14	24	plaques	plaque	NOUN
dpc-4184	14	25	was	be	AUX
dpc-4184	14	26	observed	observe	VERB
dpc-4184	14	27	after	after	ADP
dpc-4184	14	28	4	4	NUM
dpc-4184	14	29	months	month	NOUN
dpc-4184	14	30	.	.	PUNCT
dpc-4184	15	1	in	in	ADP
dpc-4184	15	2	the	the	DET
dpc-4184	15	3	meantime	meantime	NOUN
dpc-4184	15	4	,	,	PUNCT
dpc-4184	15	5	however	however	ADV
dpc-4184	15	6	,	,	PUNCT
dpc-4184	15	7	the	the	DET
dpc-4184	15	8	patient	patient	NOUN
dpc-4184	15	9	developed	develop	VERB
dpc-4184	15	10	significant	significant	ADJ
dpc-4184	15	11	eyelid	eyelid	NOUN
dpc-4184	15	12	impairment	impairment	NOUN
dpc-4184	15	13	.	.	PUNCT
dpc-4184	16	1	on	on	ADP
dpc-4184	16	2	examination	examination	NOUN
dpc-4184	16	3	,	,	PUNCT
dpc-4184	16	4	the	the	DET
dpc-4184	16	5	eyelids	eyelid	NOUN
dpc-4184	16	6	were	be	AUX
dpc-4184	16	7	mildly	mildly	ADV
dpc-4184	16	8	edematous	edematous	ADJ
dpc-4184	16	9	,	,	PUNCT
dpc-4184	16	10	slightly	slightly	ADV
dpc-4184	16	11	oozing	oozing	ADJ
dpc-4184	16	12	with	with	ADP
dpc-4184	16	13	marked	mark	VERB
dpc-4184	16	14	erythema	erythema	ADJ
dpc-4184	16	15	and	and	CCONJ
dpc-4184	16	16	scaling	scaling	NOUN
dpc-4184	16	17	.	.	PUNCT
dpc-4184	17	1	the	the	DET
dpc-4184	17	2	patient	patient	NOUN
dpc-4184	17	3	denied	deny	VERB
dpc-4184	17	4	using	use	VERB
dpc-4184	17	5	any	any	DET
dpc-4184	17	6	eye	eye	NOUN
dpc-4184	17	7	drops	drop	NOUN
dpc-4184	17	8	or	or	CCONJ
dpc-4184	17	9	cosmetics	cosmetic	NOUN
dpc-4184	17	10	,	,	PUNCT
dpc-4184	17	11	so	so	ADV
dpc-4184	17	12	allergic	allergic	ADJ
dpc-4184	17	13	contact	contact	NOUN
dpc-4184	17	14	dermatitis	dermatitis	NOUN
dpc-4184	17	15	was	be	AUX
dpc-4184	17	16	ruled	rule	VERB
dpc-4184	17	17	out	out	ADP
dpc-4184	17	18	.	.	PUNCT
dpc-4184	18	1	she	she	PRON
dpc-4184	18	2	had	have	VERB
dpc-4184	18	3	no	no	DET
dpc-4184	18	4	history	history	NOUN
dpc-4184	18	5	of	of	ADP
dpc-4184	18	6	atopic	atopic	NOUN
dpc-4184	18	7	dermatitis	dermatitis	NOUN
dpc-4184	18	8	.	.	PUNCT
dpc-4184	19	1	treatment	treatment	NOUN
dpc-4184	19	2	with	with	ADP
dpc-4184	19	3	topical	topical	ADJ
dpc-4184	19	4	corticosteroids	corticosteroid	NOUN
dpc-4184	19	5	slightly	slightly	ADV
dpc-4184	19	6	improved	improve	VERB
dpc-4184	19	7	eyelid	eyelid	NOUN
dpc-4184	19	8	lesions	lesion	NOUN
dpc-4184	19	9	in	in	ADP
dpc-4184	19	10	two	two	NUM
dpc-4184	19	11	weeks	week	NOUN
dpc-4184	19	12	.	.	PUNCT
dpc-4184	20	1	an	an	DET
dpc-4184	20	2	eczematous	eczematous	ADJ
dpc-4184	20	3	reaction	reaction	NOUN
dpc-4184	20	4	to	to	ADP
dpc-4184	20	5	an	an	DET
dpc-4184	20	6	anti	anti	ADJ
dpc-4184	20	7	-	-	ADJ
dpc-4184	20	8	il-17	il-17	ADV
dpc-4184	20	9	drug	drug	NOUN
dpc-4184	20	10	was	be	AUX
dpc-4184	20	11	suspected	suspect	VERB
dpc-4184	20	12	and	and	CCONJ
dpc-4184	20	13	the	the	DET
dpc-4184	20	14	therapy	therapy	NOUN
dpc-4184	20	15	was	be	AUX
dpc-4184	20	16	changed	change	VERB
dpc-4184	20	17	to	to	ADP
dpc-4184	20	18	an	an	DET
dpc-4184	20	19	il-23	il-23	NOUN
dpc-4184	20	20	inhibitor	inhibitor	NOUN
dpc-4184	20	21	(	(	PUNCT
dpc-4184	20	22	risankizumab	risankizumab	NOUN
dpc-4184	20	23	)	)	PUNCT
dpc-4184	20	24	,	,	PUNCT
dpc-4184	20	25	observing	observe	VERB
dpc-4184	20	26	a	a	DET
dpc-4184	20	27	fast	fast	ADJ
dpc-4184	20	28	remission	remission	NOUN
dpc-4184	20	29	of	of	ADP
dpc-4184	20	30	the	the	DET
dpc-4184	20	31	skin	skin	NOUN
dpc-4184	20	32	lesions	lesion	NOUN
dpc-4184	20	33	.	.	PUNCT
dpc-4184	21	1	figure	figure	NOUN
dpc-4184	21	2	1	1	NUM
dpc-4184	21	3	.	.	NOUN
dpc-4184	21	4	erythema	erythema	ADJ
dpc-4184	21	5	and	and	CCONJ
dpc-4184	21	6	slight	slight	ADJ
dpc-4184	21	7	edema	edema	NOUN
dpc-4184	21	8	of	of	ADP
dpc-4184	21	9	the	the	DET
dpc-4184	21	10	eyelids	eyelid	NOUN
dpc-4184	21	11	with	with	ADP
dpc-4184	21	12	flaking	flake	VERB
dpc-4184	21	13	scales	scale	NOUN
dpc-4184	21	14	,	,	PUNCT
dpc-4184	21	15	which	which	PRON
dpc-4184	21	16	developed	develop	VERB
dpc-4184	21	17	4	4	NUM
dpc-4184	21	18	months	month	NOUN
dpc-4184	21	19	after	after	ADP
dpc-4184	21	20	the	the	DET
dpc-4184	21	21	initiation	initiation	NOUN
dpc-4184	21	22	of	of	ADP
dpc-4184	21	23	secukinumab	secukinumab	NOUN
dpc-4184	21	24	for	for	ADP
dpc-4184	21	25	treating	treat	VERB
dpc-4184	21	26	psoriasis	psoriasis	NOUN
dpc-4184	21	27	.	.	PUNCT
dpc-4184	22	1	2	2	NUM
dpc-4184	22	2	image	image	NOUN
dpc-4184	22	3	letter	letter	NOUN
dpc-4184	22	4	|	|	ADV
dpc-4184	22	5	dermatol	dermatol	ADJ
dpc-4184	22	6	pract	pract	NOUN
dpc-4184	22	7	concept	concept	NOUN
dpc-4184	22	8	.	.	PUNCT
dpc-4184	23	1	2024;14(3):e2024185	2024;14(3):e2024185	NUM
dpc-4184	23	2	references	reference	NOUN
dpc-4184	23	3	1	1	NUM
dpc-4184	23	4	.	.	PUNCT
dpc-4184	24	1	teraki	teraki	PROPN
dpc-4184	24	2	y	y	PROPN
dpc-4184	24	3	,	,	PUNCT
dpc-4184	24	4	takahashi	takahashi	PROPN
dpc-4184	24	5	a	a	PROPN
dpc-4184	24	6	,	,	PUNCT
dpc-4184	24	7	inoue	inoue	PROPN
dpc-4184	24	8	y	y	PROPN
dpc-4184	24	9	,	,	PUNCT
dpc-4184	24	10	takamura	takamura	NOUN
dpc-4184	24	11	s.	s.	PROPN
dpc-4184	24	12	eyelid	eyelid	PROPN
dpc-4184	24	13	dermatitis	dermatitis	PROPN
dpc-4184	24	14	as	as	ADP
dpc-4184	24	15	a	a	DET
dpc-4184	24	16	side	side	ADJ
dpc-4184	24	17	effect	effect	NOUN
dpc-4184	24	18	of	of	ADP
dpc-4184	24	19	interleukin-17a	interleukin-17a	PROPN
dpc-4184	24	20	inhibitors	inhibitor	NOUN
dpc-4184	24	21	in	in	ADP
dpc-4184	24	22	psoriasis	psoriasis	NOUN
dpc-4184	24	23	.	.	PUNCT
dpc-4184	25	1	acta	acta	PROPN
dpc-4184	25	2	derm	derm	PROPN
dpc-4184	25	3	venereol	venereol	NOUN
dpc-4184	25	4	.	.	PUNCT
dpc-4184	26	1	2018;98(4):456	2018;98(4):456	NUM
dpc-4184	26	2	-	-	SYM
dpc-4184	26	3	457	457	NUM
dpc-4184	26	4	.	.	PUNCT
dpc-4184	27	1	doi	doi	NOUN
dpc-4184	27	2	:	:	PUNCT
dpc-4184	27	3	10.2340/00015555	10.2340/00015555	NUM
dpc-4184	27	4	-2871	-2871	NOUN
dpc-4184	27	5	.	.	PUNCT
dpc-4184	28	1	pmid	pmid	NOUN
dpc-4184	28	2	:	:	PUNCT
dpc-4184	28	3	29327064	29327064	NUM
dpc-4184	28	4	.	.	PUNCT
dpc-4184	29	1	2	2	X
dpc-4184	29	2	.	.	X
dpc-4184	29	3	alsenaid	alsenaid	VERB
dpc-4184	29	4	a	a	X
dpc-4184	29	5	,	,	PUNCT
dpc-4184	29	6	piguet	piguet	PROPN
dpc-4184	29	7	v	v	PROPN
dpc-4184	29	8	,	,	PUNCT
dpc-4184	29	9	lansang	lansang	PROPN
dpc-4184	29	10	p	p	PROPN
dpc-4184	29	11	,	,	PUNCT
dpc-4184	29	12	miller	miller	PROPN
dpc-4184	29	13	-	-	PUNCT
dpc-4184	29	14	monthrope	monthrope	PROPN
dpc-4184	29	15	y	y	PROPN
dpc-4184	29	16	,	,	PUNCT
dpc-4184	29	17	yeung	yeung	PROPN
dpc-4184	29	18	j	j	PROPN
dpc-4184	29	19	,	,	PUNCT
dpc-4184	29	20	joseph	joseph	PROPN
dpc-4184	29	21	m.	m.	PROPN
dpc-4184	29	22	brodalumab	brodalumab	PROPN
dpc-4184	29	23	-	-	PUNCT
dpc-4184	29	24	induced	induce	VERB
dpc-4184	29	25	eczematous	eczematous	ADJ
dpc-4184	29	26	reactions	reaction	NOUN
dpc-4184	29	27	in	in	ADP
dpc-4184	29	28	psoriasis	psoriasis	NOUN
dpc-4184	29	29	patients	patient	NOUN
dpc-4184	29	30	:	:	PUNCT
dpc-4184	29	31	management	management	NOUN
dpc-4184	29	32	with	with	ADP
dpc-4184	29	33	switching	switch	VERB
dpc-4184	29	34	to	to	PART
dpc-4184	29	35	risankizumab	risankizumab	VERB
dpc-4184	29	36	.	.	PUNCT
dpc-4184	30	1	j	j	PROPN
dpc-4184	30	2	cutan	cutan	PROPN
dpc-4184	30	3	med	med	ADJ
dpc-4184	30	4	surg	surg	NOUN
dpc-4184	30	5	.	.	PUNCT
dpc-4184	31	1	2023;27(3):236	2023;27(3):236	NUM
dpc-4184	31	2	-	-	SYM
dpc-4184	31	3	240	240	NUM
dpc-4184	31	4	.	.	PUNCT
dpc-4184	31	5	doi	doi	NOUN
dpc-4184	31	6	:	:	PUNCT
dpc-4184	31	7	10.1177	10.1177	NUM
dpc-4184	31	8	/12034754231167140	/12034754231167140	PUNCT
dpc-4184	31	9	.	.	PUNCT
dpc-4184	32	1	pmid	pmid	NOUN
dpc-4184	32	2	:	:	PUNCT
dpc-4184	32	3	37014149.references	37014149.references	PRON
dpc-4184	32	4	3	3	X
dpc-4184	32	5	.	.	PUNCT
dpc-4184	32	6	teraki	teraki	PROPN
dpc-4184	32	7	y	y	PROPN
dpc-4184	32	8	,	,	PUNCT
dpc-4184	32	9	takahashi	takahashi	PROPN
dpc-4184	32	10	a	a	PROPN
dpc-4184	32	11	,	,	PUNCT
dpc-4184	32	12	inoue	inoue	PROPN
dpc-4184	32	13	y	y	PROPN
dpc-4184	32	14	,	,	PUNCT
dpc-4184	32	15	takamura	takamura	NOUN
dpc-4184	32	16	s.	s.	PROPN
dpc-4184	32	17	eyelid	eyelid	PROPN
dpc-4184	32	18	dermatitis	dermatitis	PROPN
dpc-4184	32	19	as	as	ADP
dpc-4184	32	20	a	a	DET
dpc-4184	32	21	side	side	ADJ
dpc-4184	32	22	effect	effect	NOUN
dpc-4184	32	23	of	of	ADP
dpc-4184	32	24	interleukin-17a	interleukin-17a	PROPN
dpc-4184	32	25	inhibitors	inhibitor	NOUN
dpc-4184	32	26	in	in	ADP
dpc-4184	32	27	psoriasis	psoriasis	NOUN
dpc-4184	32	28	.	.	PUNCT
dpc-4184	33	1	acta	acta	PROPN
dpc-4184	33	2	derm	derm	PROPN
dpc-4184	33	3	venereol	venereol	NOUN
dpc-4184	33	4	.	.	PUNCT
dpc-4184	34	1	2018;98(4):456	2018;98(4):456	NUM
dpc-4184	34	2	-	-	SYM
dpc-4184	34	3	457	457	NUM
dpc-4184	34	4	.	.	PUNCT
dpc-4184	35	1	doi	doi	NOUN
dpc-4184	35	2	:	:	PUNCT
dpc-4184	35	3	10.2340/00015555	10.2340/00015555	NUM
dpc-4184	35	4	-2871	-2871	NOUN
dpc-4184	35	5	.	.	PUNCT
dpc-4184	36	1	pmid	pmid	NOUN
dpc-4184	36	2	:	:	PUNCT
dpc-4184	36	3	29327064	29327064	NUM
dpc-4184	36	4	.	.	PUNCT
dpc-4184	37	1	4	4	X
dpc-4184	37	2	.	.	X
dpc-4184	37	3	alsenaid	alsenaid	VERB
dpc-4184	37	4	a	a	X
dpc-4184	37	5	,	,	PUNCT
dpc-4184	37	6	piguet	piguet	PROPN
dpc-4184	37	7	v	v	PROPN
dpc-4184	37	8	,	,	PUNCT
dpc-4184	37	9	lansang	lansang	PROPN
dpc-4184	37	10	p	p	PROPN
dpc-4184	37	11	,	,	PUNCT
dpc-4184	37	12	miller	miller	PROPN
dpc-4184	37	13	-	-	PUNCT
dpc-4184	37	14	monthrope	monthrope	PROPN
dpc-4184	37	15	y	y	PROPN
dpc-4184	37	16	,	,	PUNCT
dpc-4184	37	17	yeung	yeung	PROPN
dpc-4184	37	18	j	j	PROPN
dpc-4184	37	19	,	,	PUNCT
dpc-4184	37	20	joseph	joseph	PROPN
dpc-4184	37	21	m.	m.	PROPN
dpc-4184	37	22	brodalumab	brodalumab	PROPN
dpc-4184	37	23	-	-	PUNCT
dpc-4184	37	24	induced	induce	VERB
dpc-4184	37	25	eczematous	eczematous	ADJ
dpc-4184	37	26	reactions	reaction	NOUN
dpc-4184	37	27	in	in	ADP
dpc-4184	37	28	psoriasis	psoriasis	NOUN
dpc-4184	37	29	patients	patient	NOUN
dpc-4184	37	30	:	:	PUNCT
dpc-4184	37	31	management	management	NOUN
dpc-4184	37	32	with	with	ADP
dpc-4184	37	33	switching	switch	VERB
dpc-4184	37	34	to	to	PART
dpc-4184	37	35	risankizumab	risankizumab	VERB
dpc-4184	37	36	.	.	PUNCT
dpc-4184	38	1	j	j	PROPN
dpc-4184	38	2	cutan	cutan	PROPN
dpc-4184	38	3	med	med	ADJ
dpc-4184	38	4	surg	surg	NOUN
dpc-4184	38	5	.	.	PUNCT
dpc-4184	39	1	2023;27(3):236	2023;27(3):236	NUM
dpc-4184	39	2	-	-	SYM
dpc-4184	39	3	240	240	NUM
dpc-4184	39	4	.	.	PUNCT
dpc-4184	39	5	doi	doi	NOUN
dpc-4184	39	6	:	:	PUNCT
dpc-4184	39	7	10.1177	10.1177	NUM
dpc-4184	39	8	/12034754231167140	/12034754231167140	PUNCT
dpc-4184	39	9	.	.	PUNCT
dpc-4184	40	1	pmid	pmid	NOUN
dpc-4184	40	2	:	:	PUNCT
dpc-4184	40	3	37014149.figure	37014149.figure	NUM
dpc-4184	40	4	1	1	NUM
dpc-4184	40	5	.	.	PUNCT
dpc-4184	40	6	erythema	erythema	ADJ
dpc-4184	40	7	and	and	CCONJ
dpc-4184	40	8	slight	slight	ADJ
dpc-4184	40	9	edema	edema	NOUN
dpc-4184	40	10	of	of	ADP
dpc-4184	40	11	the	the	DET
dpc-4184	40	12	eyelids	eyelid	NOUN
dpc-4184	40	13	with	with	ADP
dpc-4184	40	14	flaking	flake	VERB
dpc-4184	40	15	scales	scale	NOUN
dpc-4184	40	16	,	,	PUNCT
dpc-4184	40	17	which	which	PRON
dpc-4184	40	18	developed	develop	VERB
dpc-4184	40	19	4	4	NUM
dpc-4184	40	20	months	month	NOUN
dpc-4184	40	21	after	after	ADP
dpc-4184	40	22	the	the	DET
dpc-4184	40	23	initiation	initiation	NOUN
dpc-4184	40	24	of	of	ADP
dpc-4184	40	25	secukinumab	secukinumab	NOUN
dpc-4184	40	26	for	for	ADP
dpc-4184	40	27	treating	treat	VERB
dpc-4184	40	28	psoriasis	psoriasis	NOUN
dpc-4184	40	29	.	.	PUNCT
dpc-4184	41	1	teaching	teaching	NOUN
dpc-4184	41	2	point	point	NOUN
dpc-4184	41	3	in	in	ADP
dpc-4184	41	4	the	the	DET
dpc-4184	41	5	literature	literature	NOUN
dpc-4184	41	6	is	be	AUX
dpc-4184	41	7	reported	report	VERB
dpc-4184	41	8	that	that	SCONJ
dpc-4184	41	9	eczema	eczema	NOUN
dpc-4184	41	10	could	could	AUX
dpc-4184	41	11	be	be	AUX
dpc-4184	41	12	an	an	DET
dpc-4184	41	13	adverse	adverse	ADJ
dpc-4184	41	14	event	event	NOUN
dpc-4184	41	15	(	(	PUNCT
dpc-4184	41	16	ae	ae	PROPN
dpc-4184	41	17	)	)	PUNCT
dpc-4184	41	18	of	of	ADP
dpc-4184	41	19	il-17	il-17	NUM
dpc-4184	41	20	inhibitors	inhibitor	NOUN
dpc-4184	41	21	.	.	PUNCT
dpc-4184	42	1	regarding	regard	VERB
dpc-4184	42	2	blepharitis	blepharitis	NOUN
dpc-4184	42	3	,	,	PUNCT
dpc-4184	42	4	other	other	ADJ
dpc-4184	42	5	cases	case	NOUN
dpc-4184	42	6	reported	report	VERB
dpc-4184	42	7	argue	argue	VERB
dpc-4184	42	8	that	that	SCONJ
dpc-4184	42	9	it	it	PRON
dpc-4184	42	10	could	could	AUX
dpc-4184	42	11	be	be	AUX
dpc-4184	42	12	a	a	DET
dpc-4184	42	13	class	class	NOUN
dpc-4184	42	14	ae	ae	PROPN
dpc-4184	42	15	of	of	ADP
dpc-4184	42	16	il17a	il17a	PROPN
dpc-4184	42	17	inhibitors	inhibitor	NOUN
dpc-4184	42	18	:	:	PUNCT
dpc-4184	42	19	these	these	DET
dpc-4184	42	20	cytokines	cytokine	NOUN
dpc-4184	42	21	are	be	AUX
dpc-4184	42	22	essential	essential	ADJ
dpc-4184	42	23	for	for	ADP
dpc-4184	42	24	antimicrobial	antimicrobial	ADJ
dpc-4184	42	25	peptide	peptide	NOUN
dpc-4184	42	26	production	production	NOUN
dpc-4184	42	27	on	on	ADP
dpc-4184	42	28	the	the	DET
dpc-4184	42	29	skin	skin	NOUN
dpc-4184	42	30	surface	surface	NOUN
dpc-4184	42	31	and	and	CCONJ
dpc-4184	42	32	their	their	PRON
dpc-4184	42	33	targeting	targeting	NOUN
dpc-4184	42	34	can	can	AUX
dpc-4184	42	35	result	result	VERB
dpc-4184	42	36	in	in	ADP
dpc-4184	42	37	an	an	DET
dpc-4184	42	38	overgrowth	overgrowth	NOUN
dpc-4184	42	39	of	of	ADP
dpc-4184	42	40	microorganisms	microorganism	NOUN
dpc-4184	42	41	such	such	ADJ
dpc-4184	42	42	as	as	ADP
dpc-4184	42	43	malassezia	malassezia	NOUN
dpc-4184	42	44	,	,	PUNCT
dpc-4184	42	45	which	which	PRON
dpc-4184	42	46	might	might	AUX
dpc-4184	42	47	contribute	contribute	VERB
dpc-4184	42	48	to	to	ADP
dpc-4184	42	49	the	the	DET
dpc-4184	42	50	development	development	NOUN
dpc-4184	42	51	of	of	ADP
dpc-4184	42	52	eyelid	eyelid	PROPN
dpc-4184	42	53	dermatitis	dermatitis	NOUN
dpc-4184	42	54	[	[	X
dpc-4184	42	55	1	1	NUM
dpc-4184	42	56	]	]	PUNCT
dpc-4184	42	57	.	.	PUNCT
dpc-4184	43	1	in	in	ADP
dpc-4184	43	2	case	case	NOUN
dpc-4184	43	3	of	of	ADP
dpc-4184	43	4	severe	severe	ADJ
dpc-4184	43	5	eczematous	eczematous	ADJ
dpc-4184	43	6	reaction	reaction	NOUN
dpc-4184	43	7	to	to	ADP
dpc-4184	43	8	anti	anti	NOUN
dpc-4184	43	9	-	-	VERB
dpc-4184	43	10	il-17	il-17	NUM
dpc-4184	43	11	,	,	PUNCT
dpc-4184	43	12	some	some	DET
dpc-4184	43	13	authors	author	NOUN
dpc-4184	43	14	suggest	suggest	VERB
dpc-4184	43	15	discontinuing	discontinuing	NOUN
dpc-4184	43	16	therapy	therapy	NOUN
dpc-4184	43	17	and	and	CCONJ
dpc-4184	43	18	switching	switch	VERB
dpc-4184	43	19	to	to	ADP
dpc-4184	43	20	a	a	DET
dpc-4184	43	21	different	different	ADJ
dpc-4184	43	22	drug	drug	NOUN
dpc-4184	43	23	class	class	NOUN
dpc-4184	43	24	such	such	ADJ
dpc-4184	43	25	as	as	ADP
dpc-4184	43	26	il-23	il-23	ADJ
dpc-4184	43	27	inhibitors	inhibitor	NOUN
dpc-4184	43	28	[	[	X
dpc-4184	43	29	2	2	NUM
dpc-4184	43	30	]	]	PUNCT
dpc-4184	43	31	.	.	PUNCT
dpc-4184	44	1	this	this	PRON
dpc-4184	44	2	is	be	AUX
dpc-4184	44	3	a	a	DET
dpc-4184	44	4	valuable	valuable	ADJ
dpc-4184	44	5	option	option	NOUN
dpc-4184	44	6	for	for	ADP
dpc-4184	44	7	eyelid	eyelid	NOUN
dpc-4184	44	8	dermatitis	dermatitis	NOUN
dpc-4184	44	9	that	that	PRON
dpc-4184	44	10	does	do	AUX
dpc-4184	44	11	not	not	PART
dpc-4184	44	12	clear	clear	VERB
dpc-4184	44	13	with	with	ADP
dpc-4184	44	14	topical	topical	ADJ
dpc-4184	44	15	therapy	therapy	NOUN
dpc-4184	44	16	or	or	CCONJ
dpc-4184	44	17	often	often	ADV
dpc-4184	44	18	recurs	recur	VERB
dpc-4184	44	19	after	after	SCONJ
dpc-4184	44	20	treatment	treatment	NOUN
dpc-4184	44	21	is	be	AUX
dpc-4184	44	22	stopped	stop	VERB
dpc-4184	44	23	.	.	PUNCT